Page last updated: 2024-10-17

lactic acid and Acanthosis Nigricans

lactic acid has been researched along with Acanthosis Nigricans in 2 studies

Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.

Acanthosis Nigricans: A circumscribed melanosis consisting of a brown-pigmented, velvety verrucosity or fine papillomatosis appearing in the axillae and other body folds. It occurs in association with endocrine disorders, underlying malignancy, administration of certain drugs, or as in inherited disorder.

Research Excerpts

ExcerptRelevanceReference
"05% tretinoin cream to treat AN associated with obesity."7.72Topical therapy with tretinoin and ammonium lactate for acanthosis nigricans associated with obesity. ( Blobstein, SH, 2003)
"05% tretinoin cream to treat AN associated with obesity."3.72Topical therapy with tretinoin and ammonium lactate for acanthosis nigricans associated with obesity. ( Blobstein, SH, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Denadai, R1
Souto, RM1
Auada-Souto, MP1
Blobstein, SH1

Other Studies

2 other studies available for lactic acid and Acanthosis Nigricans

ArticleYear
Generalized acanthosis nigricans without systemic disease associated.
    Dermatology online journal, 2013, Sep-14, Volume: 19, Issue:9

    Topics: Acanthosis Nigricans; Adolescent; Dermatologic Agents; Disease Progression; Drug Therapy, Combinatio

2013
Topical therapy with tretinoin and ammonium lactate for acanthosis nigricans associated with obesity.
    Cutis, 2003, Volume: 71, Issue:1

    Topics: Acanthosis Nigricans; Administration, Topical; Adolescent; Drug Therapy, Combination; Humans; Kerato

2003